Intrinsic Value of S&P & Nasdaq Contact Us

Healthpeak Properties, Inc. DOC NYSE

NYSE • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
57/100
2/7 Pass
SharesGrow Intrinsic Value
$28.42
+68.4%
Analyst Price Target
$18.00
+6.7%

Healthpeak Properties, Inc. (DOC) — Analyst outlook / Analyst consensus target is. Based on 40 analyst ratings, the consensus is bullish — 22 Buy, 18 Hold.

The consensus price target is $18.00 (low: $17.00, high: $21.00), representing an upside of 6.7% from the current price $16.87.

Analysts estimate Earnings Per Share (EPS) of $0.40 and revenue of $2.67B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.36 vs est $0.40 (missed -9.1%). 2025: actual $0.10 vs est $0.01 (beat +1200.4%). Analyst accuracy: 49%.

DOC Stock — 12-Month Price Forecast

$18.00
▲ +6.70% Upside
Average Price Target
Based on 40 Wall Street analysts offering 12-month price targets for Healthpeak Properties, Inc., the average price target is $18.00, with a high forecast of $21.00, and a low forecast of $17.00.
The average price target represents a +6.70% change from the last price of $16.87.
Highest Price Target
$21.00
Average Price Target
$18.00
Lowest Price Target
$17.00

DOC Analyst Ratings

Buy
40
Ratings
22 Buy
18 Hold
Based on 40 analysts giving stock ratings to Healthpeak Properties, Inc. in the past 3 months
Rating breakdown
Buy
22 55%
Hold
18 45%
55%
Buy
22 analysts
45%
Hold
18 analysts
0%
Sell
0 analysts

EPS Estimates — DOC

49%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.36 vs Est $0.40 ▼ 10.0% off
2025 Actual $0.10 vs Est $0.01 ▲ 92.3% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — DOC

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $2.700B vs Est $2.668B ▲ 1.2% off
2025 Actual $2.823B vs Est $2.757B ▲ 2.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message